{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:20:05Z","timestamp":1789147205787,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guizhou Provincial Science and Technology Department, Guizhou Provincial Basic Research Plan (Natural Science) Project","award":["ZK [2023] General 330"],"award-info":[{"award-number":["ZK [2023] General 330"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04151-9","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T03:27:19Z","timestamp":1752204439000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tanshinone regulated gut microbiota and TMAO to improve high-fat diet induced atherosclerosis in APOE\u2212\/\u2212 mice"],"prefix":"10.1186","volume":"25","author":[{"given":"Aiming","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"issue":"10","key":"4151_CR1","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","volume":"185","author":"JLM Bj\u00f6rkegren","year":"2022","unstructured":"Bj\u00f6rkegren JLM, Lusis AJ. Atherosclerosis: recent developments. Cell. 2022;185(10):1630\u201345. https:\/\/doi.org\/10.1016\/j.cell.2022.04.004.","journal-title":"Cell"},{"issue":"1","key":"4151_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2011.06.041","volume":"220","author":"S Gao","year":"2012","unstructured":"Gao S, Liu Z, Li H, Little PJ, Liu P, Xu S. Cardiovascular actions and therapeutic potential of tanshinone IIA. Atherosclerosis. 2012;220(1):3\u201310. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.06.041.","journal-title":"Atherosclerosis"},{"issue":"4","key":"4151_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/19490976.2018.1465157","volume":"9","author":"AC Gomes","year":"2018","unstructured":"Gomes AC, Hoffmann C, Mota JF. The human gut microbiota: metabolism and perspective in obesity. Gut Microbes. 2018;9(4):308\u201325. https:\/\/doi.org\/10.1080\/19490976.2018.1465157.","journal-title":"Gut Microbes"},{"key":"4151_CR4","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.2147\/dddt.S266911","volume":"14","author":"R Guo","year":"2020","unstructured":"Guo R, Li L, Su J, Li S, Duncan SE, Liu Z, Fan G. Pharmacological activity and mechanism of Tanshinone IIA in related diseases. Drug Des Devel Ther. 2020;14:4735\u201348. https:\/\/doi.org\/10.2147\/dddt.S266911.","journal-title":"Drug Des Devel Ther"},{"key":"4151_CR5","doi-asserted-by":"publisher","first-page":"102590","DOI":"10.1016\/j.ebiom.2019.11.051","volume":"51","author":"M Gurung","year":"2020","unstructured":"Gurung M, Li Z, You H, Rodrigues R, Jump DB, Morgun A, Shulzhenko N. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine. 2020;51:102590. https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.051.","journal-title":"EBioMedicine"},{"issue":"4","key":"4151_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrcardio.2016.5","volume":"13","author":"DJ Hausenloy","year":"2016","unstructured":"Hausenloy DJ, Yellon DM. Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol. 2016;13(4):193\u2013209. https:\/\/doi.org\/10.1038\/nrcardio.2016.5.","journal-title":"Nat Reviews Cardiol"},{"issue":"8","key":"4151_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","volume":"24","author":"ER Mann","year":"2024","unstructured":"Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol. 2024;24(8):577\u201395. https:\/\/doi.org\/10.1038\/s41577-024-01014-8.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"4151_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrcardio.2016.183","volume":"14","author":"AL Jonsson","year":"2017","unstructured":"Jonsson AL, B\u00e4ckhed F. Role of gut microbiota in atherosclerosis. Nat Reviews Cardiol. 2017;14(2):79\u201387. https:\/\/doi.org\/10.1038\/nrcardio.2016.183.","journal-title":"Nat Reviews Cardiol"},{"issue":"10","key":"4151_CR9","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1093\/cvr\/cvz135","volume":"115","author":"T Katsimichas","year":"2019","unstructured":"Katsimichas T, Antonopoulos AS, Katsimichas A, Ohtani T, Sakata Y, Tousoulis D. The intestinal microbiota and cardiovascular disease. Cardiovasc Res. 2019;115(10):1471\u201386. https:\/\/doi.org\/10.1093\/cvr\/cvz135.","journal-title":"Cardiovascular Res"},{"issue":"2","key":"4151_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2005.01.012","volume":"181","author":"T Nakamura","year":"2005","unstructured":"Nakamura T, Takano H, Umetani K, Kawabata K, Obata JE, Kitta Y, Kodama Y, Mende A, Ichigi Y, Fujioka D, et al. Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome. Atherosclerosis. 2005;181(2):321\u20137. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2005.01.012.","journal-title":"Atherosclerosis"},{"issue":"2","key":"4151_CR11","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1530\/jme-13-0079","volume":"51","author":"AL Neves","year":"2013","unstructured":"Neves AL, Coelho J, Couto L, Leite-Moreira A, Roncon-Albuquerque R Jr. Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk. J Mol Endocrinol. 2013;51(2):R51\u201364. https:\/\/doi.org\/10.1530\/jme-13-0079.","journal-title":"J Mol Endocrinol"},{"key":"4151_CR12","doi-asserted-by":"publisher","first-page":"7805115","DOI":"10.1155\/2022\/7805115","volume":"2022","author":"M Pan","year":"2022","unstructured":"Pan M, Zhang F, Qu K, Liu C, Zhang J. TXNIP: A Double-Edged sword in disease and therapeutic outlook. Oxidative Med Cell Longev. 2022;2022:7805115. https:\/\/doi.org\/10.1155\/2022\/7805115.","journal-title":"Oxidative Med Cell Longev"},{"key":"4151_CR13","doi-asserted-by":"publisher","first-page":"26745","DOI":"10.1038\/srep26745","volume":"6","author":"E Randrianarisoa","year":"2016","unstructured":"Randrianarisoa E, Lehn-Stefan A, Wang X, Hoene M, Peter A, Heinzmann SS, Zhao X, K\u00f6nigsrainer I, K\u00f6nigsrainer A, Balletshofer B, et al. Relationship of serum trimethylamine N-Oxide (TMAO) levels with early atherosclerosis in humans. Sci Rep. 2016;6:26745. https:\/\/doi.org\/10.1038\/srep26745.","journal-title":"Sci Rep"},{"issue":"12","key":"4151_CR14","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s12012-024-09928-4","volume":"24","author":"T Zhu","year":"2024","unstructured":"Zhu T, Chen J, Zhang M, Tang Z, Tong J, Hao X, Li H, Xu J, Yang J. Tanshinone IIA exerts cardioprotective effects through improving gut-brain axis post-myocardial infarction. Cardiovasc Toxicol. 2024;24(12):1317\u201334. https:\/\/doi.org\/10.1007\/s12012-024-09928-4.","journal-title":"Cardiovasc Toxicol"},{"key":"4151_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/b978-0-12-800100-4.00003-9","volume":"121","author":"J Tan","year":"2014","unstructured":"Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. The role of short-chain fatty acids in health and disease. Adv Immunol. 2014;121:91\u2013119. https:\/\/doi.org\/10.1016\/b978-0-12-800100-4.00003-9.","journal-title":"Adv Immunol"},{"issue":"2","key":"4151_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cmet.2022.12.013","volume":"35","author":"T Takeuchi","year":"2023","unstructured":"Takeuchi T, Kameyama K, Miyauchi E, Nakanishi Y, Kanaya T, Fujii T, Kato T, Sasaki T, Tachibana N, Negishi H, et al. Fatty acid overproduction by gut commensal microbiota exacerbates obesity. Cell Metabol. 2023;35(2):361\u201375. https:\/\/doi.org\/10.1016\/j.cmet.2022.12.013.","journal-title":"Cell Metabol"},{"key":"4151_CR17","doi-asserted-by":"publisher","unstructured":"Tian Z, Wang X, Han T, Wang M, Ning H, Sun C. Inhibition of MAOB ameliorated high-fat-diet-induced atherosclerosis by inhibiting endothelial dysfunction and modulating gut microbiota. Nutrients. 2023;15(11). https:\/\/doi.org\/10.3390\/nu15112542.","DOI":"10.3390\/nu15112542"},{"issue":"8","key":"4151_CR18","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/cir.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153. https:\/\/doi.org\/10.1161\/cir.0000000000001052.","journal-title":"Circulation"},{"key":"4151_CR19","doi-asserted-by":"publisher","unstructured":"Kolodziejczyk AA, Zheng D, Shibolet O, Elinav E. The role of the microbiome in NAFLD and NASH. EMBO Mol Med. 2019;11(2). https:\/\/doi.org\/10.15252\/emmm.201809302.","DOI":"10.15252\/emmm.201809302"},{"key":"4151_CR20","doi-asserted-by":"publisher","unstructured":"Liang X, Zhang Z, Lv Y, Tong L, Liu T, Yi H, Zhou X, Yu Z, Tian X, Cui Q, et al. Reduction of intestinal trimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis. Nutr (Burbank Los Angeles Cty Calif). 2020;79\u201380. https:\/\/doi.org\/10.1016\/j.nut.2020.110941.","DOI":"10.1016\/j.nut.2020.110941"},{"key":"4151_CR21","doi-asserted-by":"publisher","first-page":"1064872","DOI":"10.3389\/fphar.2022.1064872","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Dou C, Wei G, Zhang L, Xiong W, Wen L, Xiang C, Chen C, Zhang T, Altamirano A, et al. Usnea improves high-fat diet- and vitamin D3-induced atherosclerosis in rats by remodeling intestinal flora homeostasis. Front Pharmacol. 2022;13:1064872. https:\/\/doi.org\/10.3389\/fphar.2022.1064872.","journal-title":"Front Pharmacol"},{"key":"4151_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01082","author":"J Ma","year":"2018","unstructured":"Ma J, Li H. The role of gut microbiota in atherosclerosis and hypertension. Front Pharmacol. 2018. https:\/\/doi.org\/10.3389\/fphar.2018.01082.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4151_CR23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12967-024-05120-y","volume":"22","author":"Q Jin","year":"2024","unstructured":"Jin Q, Zhang C, Chen R, Jiang L, Li H, Wu P, Li L. Quinic acid regulated TMA\/TMAO-related lipid metabolism and vascular endothelial function through gut microbiota to inhibit atherosclerotic. J Transl Med. 2024;22(1):352. https:\/\/doi.org\/10.1186\/s12967-024-05120-y.","journal-title":"J Translational Med"},{"key":"4151_CR24","doi-asserted-by":"publisher","unstructured":"Verhaar BJH, Prodan A, Nieuwdorp M, Muller M. Gut microbiota in hypertension and atherosclerosis: a review. Nutrients. 2020;12(10). https:\/\/doi.org\/10.3390\/nu12102982.","DOI":"10.3390\/nu12102982"},{"key":"4151_CR25","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.ijbiomac.2018.01.071","volume":"111","author":"D Wang","year":"2018","unstructured":"Wang D, Sun F, Lu C, Chen P, Wang Z, Qiu Y, Mu H, Miao Z, Duan J. Inulin based glutathione-responsive delivery system for colon cancer treatment. Int J Biol Macromol. 2018;111:1264\u201372. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.01.071.","journal-title":"Int J Biol Macromol"},{"issue":"6052","key":"4151_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.1208344","volume":"334","author":"GD Wu","year":"2011","unstructured":"Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, et al. Linking long-term dietary patterns with gut microbial enterotypes. Sci (New York NY). 2011;334(6052):105\u20138. https:\/\/doi.org\/10.1126\/science.1208344.","journal-title":"Sci (New York NY)"},{"issue":"3","key":"4151_CR27","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.celrep.2014.12.036","volume":"10","author":"M Warrier","year":"2015","unstructured":"Warrier M, Shih DM, Burrows AC, Ferguson D, Gromovsky AD, Brown AL, Marshall S, McDaniel A, Schugar RC, Wang Z, et al. The TMAO-generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance. Cell Rep. 2015;10(3):326\u201338. https:\/\/doi.org\/10.1016\/j.celrep.2014.12.036.","journal-title":"Cell Rep"},{"issue":"4","key":"4151_CR28","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/circresaha.120.316242","volume":"127","author":"M Witkowski","year":"2020","unstructured":"Witkowski M, Weeks TL, Hazen SL. Gut microbiota and cardiovascular disease. Circul Res. 2020;127(4):553\u201370. https:\/\/doi.org\/10.1161\/circresaha.120.316242.","journal-title":"Circul Res"},{"issue":"2","key":"4151_CR29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jep.2007.05.026","volume":"113","author":"MH Wu","year":"2007","unstructured":"Wu MH, Tsai WJ, Don MJ, Chen YC, Chen IS, Kuo YC. Tanshinlactone A from Salvia miltiorrhiza modulates interleukin-2 and interferon-gamma gene expression. J Ethnopharmacol. 2007;113(2):210\u20137. https:\/\/doi.org\/10.1016\/j.jep.2007.05.026.","journal-title":"J Ethnopharmacol"},{"key":"4151_CR30","doi-asserted-by":"publisher","first-page":"154217","DOI":"10.1016\/j.phymed.2022.154217","volume":"102","author":"S Yan","year":"2022","unstructured":"Yan S, Chang J, Hao X, Liu J, Tan X, Geng Z, Wang Z. Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora. Phytomedicine: Int J Phytotherapy Phytopharmacology. 2022;102:154217. https:\/\/doi.org\/10.1016\/j.phymed.2022.154217.","journal-title":"Phytomedicine: Int J Phytotherapy Phytopharmacology"},{"key":"4151_CR31","doi-asserted-by":"publisher","first-page":"1321880","DOI":"10.3389\/fphar.2023.1321880","volume":"14","author":"C Yang","year":"2023","unstructured":"Yang C, Mu Y, Li S, Zhang Y, Liu X, Li J. Tanshinone IIA: a Chinese herbal ingredient for the treatment of atherosclerosis. Front Pharmacol. 2023;14:1321880. https:\/\/doi.org\/10.3389\/fphar.2023.1321880.","journal-title":"Front Pharmacol"},{"issue":"7413","key":"4151_CR32","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nature11400","volume":"488","author":"I Cho","year":"2012","unstructured":"Cho I, Yamanishi S, Cox L, Meth\u00e9 BA, Zavadil J, Li K, Gao Z, Mahana D, Raju K, Teitler I, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 2012;488(7413):621\u20136. https:\/\/doi.org\/10.1038\/nature11400.","journal-title":"Nature"},{"issue":"7418","key":"4151_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","volume":"490","author":"J Qin","year":"2012","unstructured":"Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55\u201360. https:\/\/doi.org\/10.1038\/nature11450.","journal-title":"Nature"},{"key":"4151_CR34","doi-asserted-by":"publisher","first-page":"108336","DOI":"10.1016\/j.jnutbio.2019.108336","volume":"78","author":"H Zeng","year":"2020","unstructured":"Zeng H, Larson KJ, Cheng WH, Bukowski MR, Safratowich BD, Liu Z, Hakkak R. Advanced liver steatosis accompanies an increase in hepatic inflammation, colonic, secondary bile acids and lactobacillaceae\/lachnospiraceae bacteria in C57BL\/6 mice fed a high-fat diet. J Nutr Biochem. 2020;78:108336. https:\/\/doi.org\/10.1016\/j.jnutbio.2019.108336.","journal-title":"J Nutr Biochem"},{"issue":"10","key":"4151_CR35","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.chom.2023.09.002","volume":"31","author":"CD Shelton","year":"2023","unstructured":"Shelton CD, Sing E, Mo J, Shealy NG, Yoo W, Thomas J, Fitz GN, Castro PR, Hickman TT, Torres TP, et al. An early-life microbiota metabolite protects against obesity by regulating intestinal lipid metabolism. Cell Host Microbe. 2023;31(10):1604\u201319. https:\/\/doi.org\/10.1016\/j.chom.2023.09.002.","journal-title":"Cell Host Microbe"},{"issue":"11","key":"4151_CR36","doi-asserted-by":"publisher","first-page":"e13495","DOI":"10.1111\/jfbc.13495","volume":"44","author":"Y Gan","year":"2020","unstructured":"Gan Y, Chen H, Zhou XR, Chu LL, Ran WT, Tan F, Zhao X. Regulating effect of Lactobacillus plantarum CQPC03 on lipid metabolism in high-fat diet-induced obesity in mice. J Food Biochem. 2020;44(11):e13495. https:\/\/doi.org\/10.1111\/jfbc.13495.","journal-title":"J Food Biochem"},{"issue":"7341","key":"4151_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57\u201363. https:\/\/doi.org\/10.1038\/nature09922.","journal-title":"Nature"},{"issue":"17","key":"4151_CR38","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","volume":"368","author":"WH Tang","year":"2013","unstructured":"Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575\u201384. https:\/\/doi.org\/10.1056\/NEJMoa1109400.","journal-title":"N Engl J Med"},{"issue":"5","key":"4151_CR39","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576\u201385. https:\/\/doi.org\/10.1038\/nm.3145.","journal-title":"Nat Med"},{"issue":"1","key":"4151_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","volume":"165","author":"W Zhu","year":"2016","unstructured":"Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, Li L, Fu X, Wu Y, Mehrabian M, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016;165(1):111\u201324. https:\/\/doi.org\/10.1016\/j.cell.2016.02.011.","journal-title":"Cell"},{"issue":"6","key":"4151_CR41","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cpcardiol.2018.06.005","volume":"44","author":"H Al-Rubaye","year":"2019","unstructured":"Al-Rubaye H, Perfetti G, Kaski JC. The role of microbiota in cardiovascular risk: focus on trimethylamine oxide. Curr Probl Cardiol. 2019;44(6):182\u201396. https:\/\/doi.org\/10.1016\/j.cpcardiol.2018.06.005.","journal-title":"Curr Probl Cardiol"},{"issue":"1","key":"4151_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cmet.2012.12.011","volume":"17","author":"BJ Bennett","year":"2013","unstructured":"Bennett BJ, de Aguiar Vallim TQ, Wang Z, Shih DM, Meng Y, Gregory J, Allayee H, Lee R, Graham M, Crooke R, et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metabol. 2013;17(1):49\u201360. https:\/\/doi.org\/10.1016\/j.cmet.2012.12.011.","journal-title":"Cell Metabol"},{"key":"4151_CR43","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.biopha.2017.11.016","volume":"97","author":"J Geng","year":"2018","unstructured":"Geng J, Yang C, Wang B, Zhang X, Hu T, Gu Y, Li J. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK\/JNK pathway. Biomed Pharmacother. 2018;97:941\u20137. https:\/\/doi.org\/10.1016\/j.biopha.2017.11.016.","journal-title":"Biomed pharmacotherapy = Biomedecine Pharmacotherapie"},{"issue":"25","key":"4151_CR44","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1056\/NEJMcibr1604458","volume":"374","author":"H Tilg","year":"2016","unstructured":"Tilg H. A gut feeling about thrombosis. N Engl J Med. 2016;374(25):2494\u20136. https:\/\/doi.org\/10.1056\/NEJMcibr1604458.","journal-title":"N Engl J Med"},{"key":"4151_CR45","doi-asserted-by":"publisher","unstructured":"Seldin MM, Meng Y, Qi H, Zhu W, Wang Z, Hazen SL, Lusis AJ, Shih DM. Trimethylamine N-Oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear Factor-\u03baB. J Am Heart Assoc. 2016;5(2). https:\/\/doi.org\/10.1161\/jaha.115.002767.","DOI":"10.1161\/jaha.115.002767"},{"issue":"1","key":"4151_CR46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/mol.0000000000000036","volume":"25","author":"JM Brown","year":"2014","unstructured":"Brown JM, Hazen SL. Metaorganismal nutrient metabolism as a basis of cardiovascular disease. Curr Opin Lipidol. 2014;25(1):48\u201353. https:\/\/doi.org\/10.1097\/mol.0000000000000036.","journal-title":"Curr Opin Lipidol"},{"issue":"39","key":"4151_CR47","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1093\/eurheartj\/ehx342","volume":"38","author":"GG Schiattarella","year":"2017","unstructured":"Schiattarella GG, Sannino A, Toscano E, Giugliano G, Gargiulo G, Franzone A, Trimarco B, Esposito G, Perrino C. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis. Eur Heart J. 2017;38(39):2948\u201356. https:\/\/doi.org\/10.1093\/eurheartj\/ehx342.","journal-title":"Eur Heart J"},{"issue":"7","key":"4151_CR48","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","volume":"163","author":"Z Wang","year":"2015","unstructured":"Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, Gu X, Huang Y, Zamanian-Daryoush M, Culley MK, et al. Non-lethal Inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell. 2015;163(7):1585\u201395. https:\/\/doi.org\/10.1016\/j.cell.2015.11.055.","journal-title":"Cell"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04151-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04151-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04151-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T03:27:20Z","timestamp":1752204440000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-04151-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4151"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04151-9","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This animal study was approved by the Animal Ethics Committee of Guizhou Medical University (Ethics number: 2304463).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"432"}}